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OBJECTIVES To determine the relative degree of revascularization obtained with bypass surgery versus
angioplasty in a randomized trial of patients with multivessel disease requiring revasculariza-
tion (Bypass Angioplasty Revascularization Investigation [BARI]), one-year catheterization
was performed in 15% of patients.
BACKGROUND Complete revascularization has been correlated with improved outcome after coronary artery
bypass grafting (CABG) but not with percutaneous transluminal coronary angioplasty
(PTCA). Relative degrees of revascularization after PTCA and surgery have not been
previously compared and correlated with symptoms.
METHODS Consecutive patients at four BARI centers consented to recatheterization one year after
revascularization. Myocardial jeopardy index (MJI), the percentage of myocardium jeopar-
dized by $50% stenoses, was compared and correlated with angina status.
RESULTS Angiography was completed in 270 of 362 consecutive patients (75%) after initial CABG
(n 5 135) or PTCA (n 5 135). Coronary artery bypass grafting patients had 3 6 0.9 distal
anastomoses and PTCA patients had 2.4 6 1.1 lesions attempted at initial revascularization.
At one year, 20.5% of CABG patients had $1 totally occluded graft and 86.9% of vein graft,
and 91.6% of internal mammary artery distal anastomotic sites had ,50% stenosis. One year
jeopardy index in surgery patients was 14.1 6 11%, 46.6 6 20.3% improved from baseline.
Initial PTCA was successful in 86.9% of lesions and repeat revascularization was performed
in 48.4% of PTCA patients by one year. Myocardial jeopardy index one year after PTCA was
25.5 6 22.8%, an improvement of 33.8 6 26.1% (p , 0.01 for greater improvement with
CABG than PTCA). At one year, 29.6% of PTCA patients had angina versus 11.9% of
surgery patients, p 5 0.004. One-year myocardial jeopardy was predictive of angina (odds
ratio 1.28 for the presence of angina per every 10% increment in myocardial jeopardy, p 5
0.002). Randomization to PTCA rather than CABG also predicted angina (odds ratio 2.19,
p 5 0.03).
CONCLUSIONS In this one-year angiographic substudy of BARI, CABG provided more complete revascu-
larization than PTCA, and CABG likewise improved angina to a greater extent than PTCA.
(J Am Coll Cardiol 1999;34:1750–9) © 1999 by the American College of Cardiology
By the late 1970s coronary artery bypass surgery emerged as
the standard treatment for patients with multivessel coro-
nary artery disease and severe ischemia. Surgery has been
proven to prolong life in patients with moderate and high
risk coronary disease, such as those with left main disease,
triple-vessel disease and those with multivessel disease
including significant stenosis of the proximal left anterior
descending coronary artery. In addition, bypass grafting
provides durable symptom relief in the majority of patients
regardless of their risk profile (1–9).
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Over the last 20 years, angioplasty has also become a
treatment alternative for patients with multivessel disease
(10–18). The relative merits of bypass surgery versus angio-
plasty for treatment of patients with multivessel disease and
angina or severe ischemia on exercise testing were tested in
the Bypass Angioplasty Revascularization Investigation
(BARI). Death and freedom from myocardial infarction
(MI) were not statistically different in the 1,829 patients
randomly assigned to surgery versus angioplasty at five-year
follow-up (19). However, bypass surgery patients had im-
proved symptom relief compared with those with angio-
plasty at one-year follow-up (20,21). A subset of consecu
tively randomized patients at four centers in the BARI trial
agreed to protocol catheterization at the end of one year to
determine the degree of revascularization accomplished by
the two treatment options and the relationship of the extent
of jeopardized myocardium to clinical outcome. This article
reports the results of the one-year angiographic substudy of
the BARI randomized population.
METHODS
The BARI study protocol, procedural guidelines, baseline
and five-year data have been previously published (22–26).
To summarize, patients with severe angina or objective
evidence of ischemia on exercise testing with multiple vessel
coronary disease by catheterization were eligible for BARI.
Patients requiring revascularization were reviewed and ac-
cepted as suitable candidates by both a surgeon and an
angioplasty operator. Balloon angioplasty was the only
percutaneous technique utilized in BARI, as no second
generation devices were Food and Drug Administration
approved at the beginning of the study. Between 1988 and
1991, 1,829 patients from 18 clinical centers were random-
ized in BARI. The primary end point of the trial was
five-year mortality, and all cause mortality was equal with
both strategies of initial revascularization (19).
One year substudy. A consecutive group of 362 patients
randomized in BARI at four investigative centers (Table 1)
signed informed consent including one-year angiographic
follow-up. One-year angiography was defined as either
protocol mandated or an intercurrent angiogram occurring
within a window of nine to 15 months following the
baseline arteriogram. The angiographic analysis was based
on the anatomy at one year angiography prior to any
subsequent intervention.
Coronary arteriography was performed using 7F Sones or
preformed Judkins catheters. Sublingual or intracoronary
nitroglycerin was given before right and left coronary
injections. Views taken on the initial BARI baseline film
were repeated, and additional shots were taken when nec-
essary to fully define the coronary anatomy. Percent stenosis
was determined by caliper measurement and reported for
the worst view only. Angiograms were read at a core
angiographic laboratory at Stanford University. Left ven-
triculography was also repeated in the 30° right anterior
oblique (RAO) view. Left ventricular (LV) wall motion
score was defined as the sum of five regional wall motion
scores each based on a 5-point scale (1 5 normal wall
motion, 2 5 mild to moderate hypokinesis, 3 5 severe
hypokinesis, 4 5 akinesis, 5 5 dyskinesia) (27).
A myocardial jeopardy percentage was quantitated for
each patient, with “myocardial jeopardy index (MJI)” de-
fined as the sum of the estimated percentage of LV
myocardium distal to $50% stenoses. By using a graphic
database, each patient’s coronary distribution to LV myo-
Abbreviations and Acronyms
BARI 5 Bypass Angioplasty Revascularization
Investigation
CABG 5 coronary artery bypass grafting
LV 5 left ventricular
MI 5 myocardial infarction
MJI 5 myocardial jeopardy index (the estimated
percentage of left ventricular myocardium
supplied by arteries/bypass grafts with $50%
stenosis by core laboratory assessment)
PTCA 5 percutaneous transluminal coronary
angioplasty
RAO 5 right anterior oblique
TIMI 5 Thrombolysis In Myocardial Infarction
TVR 5 target vessel revascularization
Table 1. Consecutive Patients Randomized in BARI at Four Investigative Centers
Investigative Site
Total Number
Randomized
Patients
No. Eligible
Patients Within
Consecutive
Series
No. Pts. Completing
One-Year Angiography
Cleveland Clinic 150 150* 109
Duke University 129 129* 107
Montreal Heart Institute 218 40† 33
St. Louis University 130 43‡ 21
Total 627 362 270 (75% of eligible pts.)
*Consecutive patients at these institutions were enrolled in the angiographic substudy from 8/89 to 11/92; †Consecutive patients
were enrolled in the angiographic substudy from 5/91 to 1/92; ‡Consecutive patients were enrolled in the angiographic substudy
from 10/90 to 11/91.
No. 5 number; Pts. 5 patients.
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cardium was characterized, and total LV units were com-
puted. Coronary lesions were positioned appropriately in
relation to vessel branches and bifurcations in each patient.
The total LV myocardial units jeopardized by lesions $50%
were summed. The units of LV myocardium jeopardized by
$50% lesions divided by the total LV territory units defined
the extent of myocardial jeopardy. Wall motion and previ-
ous MI were not considered in the calculation of myocardial
jeopardy (Appendix I) (28,29).
Restenosis in patients who underwent percutaneous
transluminal coronary angioplasty (PTCA) was defined as a
$50% lesion attempted at the initial PTCA having $50%
stenosis on an intercurrent angiogram or the one-year
protocol angiogram. Graft lesions were referenced against
the adjacent normal-appearing graft conduit, not the native
coronary reference vessel. In determining the frequency of
target vessel revascularization (TVR), PTCA patients who
underwent intercurrent coronary artery bypass grafting
(CABG) were assumed to have TVR on all vessel(s) treated
at the initial PTCA.
Statistical analysis. Student t test and chi-square tests
were used to compare baseline and follow-up characteristics.
Logistic regression analysis was used to determine the odds
of one-year angina by treatment assignment and myocardial
jeopardy score (in units of 10 percentage points). Adjust-
ment was made for history of smoking and angina at study
entry which were significant predictors of one-year angina
status. All analyses were conducted by the “intention to
treat” assignment, with the exception of the exclusion from
analysis of bypass surgery or angioplasty lesion outcome in
four patients who did not receive their assigned treatment.
RESULTS
Two hundred seventy of 362 consecutive eligible patients
(75%) completed follow-up angiography at the four partic-
ipating institutions. These patients comprised 15% of the
total BARI study population. Six patients assigned to
surgery in the consecutive series were deceased and 40 did
not have angiographic follow-up. Nine patients assigned to
angioplasty in the consecutive series were deceased at one
year and 37 did not have angiographic follow-up. Three
patients who were assigned CABG actually received PTCA
as initial treatment, while one patient who was randomized
to PTCA had CABG as initial treatment.
The number of patients randomized, eligible and studied
at each participating institution is listed in Table 1. The
baseline characteristics and one-year incidence of repeat
revascularization and Q-wave MI of the angiographic sub-
study patients, the consecutive patients in BARI at the four
participating institutions who were alive but not restudied
and the remaining surviving BARI randomized cohort are
compared in Table 2. Patients at participating centers
without one-year angiography were significantly older than
those undergoing one-year angiography and showed a trend
for more congestive heart failure and diabetes. In fact, the
subgroup without one-year angiography had a higher five-
year all-cause mortality (16.1%) than those undergoing
one-year angiography (5.1%, p 5 0.007). Cardiac mortality
was also higher in those not restudied (8.3%) than in those
undergoing one-year recatheterization at the angiographic
substudy sites (2.1%, p 5 0.03). Baseline LV wall motion
and myocardial jeopardy were similar in all groups. A higher
percentage of patients at the one-year angiographic sites
underwent repeat PTCA (14%) than at other BARI sites by
one year (10%, p 5 0.05). Fewer patients undergoing
one-year angiography had Q-wave MIs during the first year
(3.3%) than those at other BARI sites (6.9%, p 5 0.05).
Most important for comparison, the five-year frequency
of major adverse events (composite of cardiac death,
Q-wave MI, repeat PTCA, subsequent CABG) was com-
parable for the 270 patients completing one-year angiogra-
phy (38.2%) and the other 1,409 BARI randomized patients
alive at one year (37.4%). Therefore the one-year angio-
graphic substudy group had a similar clinical outcome to the
remaining BARI randomized patients alive at one year.
Baseline characteristics of the 270 patients in the series
completing one-year angiography are listed in Table 3
according to treatment assignment. Bypass and PTCA
patients were similar in all baseline clinical and angiographic
characteristics except that patients in the PTCA group were
more likely to have had a prior history of congestive heart
failure (9.6% vs. 3.0%, p 5 0.04).
Bypass surgery patients. Bypass surgery patients in the
angiographically restudied group had a mean of 3.6 6 1.5
lesions $50% per patient at study entry. Mean myocardial
jeopardy at baseline was 60.8 6 17.3% (Table 3), and the
cumulative percentage of patients with any specified degree
of myocardial jeopardy or less (cumulative frequency distri-
bution of myocardial jeopardy) is displayed in Figure 1.
Initial bypass surgery consisted of 3.0 distal anastomoses per
patient. Ninety percent of patients received at least one
internal mammary artery graft. Figure 2A is a flow diagram
showing the initial procedure and one-year angiographic
outcome of these patients, grafts and distal anastomotic
sites. At one year, 20.5% of CABG patients had $1 totally
occluded graft. However, 86.9% of vein graft and 91.6% of
internal mammary artery distal anastomotic sites were
patent without significant stenosis.
One year myocardial jeopardy in the surgery patients was
reduced to 14.1 6 11% (p 5 0.001), with 37.8% of patients
having a myocardial jeopardy of 0. (Fig. 1). Improvement in
myocardial jeopardy in absolute percentage units from
baseline to one-year follow-up was 46.6 6 20.3%. Repeat
revascularization (percutaneous intervention) prior to this
one-year angiogram was performed in only one surgery
patient, and no patient required repeat bypass grafting.
Baseline ejection fraction, available in 96 of 135 surgery
patients (71.1%), was 0.58 6 0.10. Paired left ventriculog-
raphy was quantitated in 68 restudied surgery patients, and
one-year ejection fraction was 0.62 6 0.13. Paired wall
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motion assessment was available in 131 patients with
one-year wall motion score of 6.4 6 2.4 and a baseline wall
motion score of 7.0 6 2.5.
One hundred nineteen of 135 (88.1%) surgery patients
were angina free at the time of one-year follow-up (Fig. 3).
Eleven patients had functional class I or II angina, while 5
patients had functional class III or IV angina.
Angioplasty patients. Angioplasty patients had 3.4 6 1.3
lesions $50% per patient at study entry, and myocardial
jeopardy at baseline was 59.4 6 16.0% (Table 3). Angio-
plasty patients had 2.4 6 1.1 lesions per patient attempted
at single or staged procedures.
One hundred twenty-four of 134 angioplasty patients
(92.5%) had at least one significant lesion successfully
dilated (#50% residual stenosis by caliper measurement
with Thrombolysis In Myocardial Infarction [TIMI] 3 flow
by core laboratory analysis). Of all attempted significant
lesions, 284 of 327 were successfully dilated (86.9%). Of the
successfully dilated lesions, 79 of 284 (27.8%) had $50%
Table 2. Baseline Characteristics and One-Year Revascularization, Myocardial Infarction
Pts. Completing
One-Year
Angiography
Pts. Alive w/o
One-Year Angiography*
All Other BARI Pts.
Alive at One Year*
N 270 77 1,409
Age (mean) 60.6 63.1† 61.4
Women (%) 30.4 35.1 25.8
Prior MI (%) 54.8 57.1 53.8
History of congestive
heart failure (%)
6.3 13.0 (p 5 0.09) 8.1
Treated diabetes (%) 17.4 27.3 (p 5 0.07) 17.9
Angina at entry (%)
CHC 0/1/2 18.5 11.7 14.8
CHC 3/4 13.7 9.1 17.3
Unstable angina 60.7 76.6 62.3
With MI only 7.1 2.6 5.6
Entry angiography
2-Vessel CAD (%)‡ 63.3 64.9 56.3
3-Vessel CAD (%)‡ 36.7 32.5 42.0†
LVWMS (5–25): (mean
per patient)
7.3 7.6 7.3
% Myocardial jeopardy
(mean)
60.1 60.5 61.5
Additional procedures§
PTCA only (%) 14.1 14.3 10.0 (p 5 0.053)
CABG (%) 9.6 10.4 11.4
Pts. with Q-wave MI
during 1st yr (%)
3.3 7.8 (p 5 0.11) 6.9†
*Among patients with one-year angiography, the mean time to angiography was 382 days. This value was used in identifying
patients alive and without one-year angiography and to determine rates of revascularization in these patients; †p , 0.05
compared with patients completing one year angiograms; ‡definition adjusts for RCA/LCA dominance; §crude rates which
ignore censoring that may have occurred due to patient study withdrawal.
CAD 5 coronary artery disease; CABG 5 coronary artery bypass grafting; LCA 5 left coronary artery; LVWMS 5 left
ventricular wall motion score; MI 5 myocardial infarction; PTCA 5 percutaneous transluminal coronary angioplasty; RCA 5
right coronary artery.
Table 3. Baseline Characteristics, Consecutive Series of Patients
Completing One-Year Angiography
CABG PTCA p
N 135 135
Age (mean) 60.2 60.9
Women (%) 31.1 29.6
Prior MI (%) 52.6 57.0
History of congestive heart failure
(%)
3.0 9.6 0.04
Treated diabetes (%) 19.3 15.6
Angina at entry (%)
CHC 0/1/2 22.2 14.8
CHC 3/4 13.3 14.1
Unstable angina 54.8 66.7
With MI only 9.6 4.4
2-Vessel CAD (%) 60.7 65.9
3-Vessel CAD (%) 39.3 34.1
Lesions $50% per patient (mean) 3.6 3.4
% Myocardial jeopardy (mean) 60.8 59.4
Ejection fraction (mean) 0.58 0.59
LV wall motion score (mean) 7.1 7.6
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stenosis at one-year follow-up. Details of angiographic
outcome of PTCA patients are delineated in Figure 2B.
Target vessel revascularization by the time of one-year
angiography was performed in 60 of 124 patients (48.4%)
with at least one initially successfully dilated lesion.
In addition to the initial angioplasty targets, 1 6 1.2
lesions per patient $50% had been untreated at the initial
angiogram. This corresponded to 72 of 134 patients (53.7%)
having at least one lesion $50% untreated at the initial
PTCA. Twenty-five patients (18.6%) had undergone cross-
over to CABG by one year, including three patients with
both repeat PTCA and subsequent CABG. Myocardial
jeopardy at one year was 25.5 6 22.8%, significantly
improved from baseline (p 5 0.001) but also significantly
higher than in bypass surgery patients (p 5 0.01) (Fig. 1).
Improvement in myocardial jeopardy from baseline was
33.8 6 26.1 percentage units, and 24.6% of PTCA patients
had a myocardial jeopardy of 0.
Baseline LV ejection fraction, available in 104 of 135
patients (77%), was 0.59 6 0.12. Paired one-year left
ventriculograms were available in 84 patients (62.2%), and
one-year LV ejection fraction was 0.61 6 0.12. Paired wall
motion assessment was available in 125 angioplasty patients
with one-year wall motion score of 7.1 6 3.1 and baseline
wall motion score of 7.7 6 3.1.
Ninety-five of 135 angioplasty patients were angina free
at the time of one-year angiography (70.4%) (Fig. 3).
Twenty-eight patients had functional class I–II angina, 9
patients had functional class III–IV angina and 3 patients
had unstable angina. Percutaneous transluminal coronary
angioplasty patients had significantly more angina than
bypass patients at one year (p 5 0.004).
Figure 1. Myocardial jeopardy percentage expressed as a cumula-
tive frequency distribution at study entry and at one year for PTCA
and surgery patients. The y axis represents the cumulative percent-
age of patients with the x axis value of myocardial jeopardy or less.
Figure 2. (A) Flow diagram showing the one-year angiographic outcome of the surgery patients, grafts and distal anastomotic sites.
(B) Details of angiographic outcome of PTCA patients are delineated. Restenosis 5 lesion $50% stenosis.
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Relation of angina and clinical events to MJI. In order to
analyze a potential independent treatment effect on the
occurrence of angina beyond the effect of extent of jeopar-
dized myocardium, patients were divided into three sub-
groups of myocardial jeopardy at one-year angiography:
,10%, 10% to 33% and .33% (Fig. 4). Within each
subgroup of myocardial jeopardy, PTCA patients reported
more angina than CABG patients, most striking in the
subgroup with .33% myocardial jeopardy (11% angina for
CABG patients vs. 49% for PTCA patients, p 5 0.004).
Patients having CABG did have more Q-wave MIs than
those with PTCA, 5.8% versus 1.9% in the subgroup with
10% to 33% MJI and 10.5% versus 0% in the $33% MJI
subgroup, p 5 0.03. More MIs in the CABG group likely
contribute to but do not fully explain the lower prevalence of
angina in CABG patients.
Figure 3. Angina status at baseline (left) and one year (right) for PTCA and CABG patients. CABG 5 coronary artery bypass grafting;
PTCA 5 percutaneous transluminal coronary angiography.
Figure 4. Angina status related to one-year myocardial jeopardy index in PTCA versus CABG patients with ,10% myocardial jeopardy
(MyoJep), 10% to 33% MyoJep and .33% MyoJep at one-year angiography. Abbreviations as in Figure 3.
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A logistic regression analysis was performed to identify
the correlates of angina at one-year follow-up. The multi-
variate model adjusted for history of angina greater than one
year at the time of randomization, smoking and Canadian
angina class 3, 4 or unstable angina at the time of random-
ization. After adjustment for these baseline variables, one-
year myocardial jeopardy was predictive of angina with an
odds ratio of 1.28 for the presence of angina per every 10%
increment in myocardial jeopardy (p 5 0.002). Initial
randomization to PTCA rather than CABG also predicted
angina at one year (adjusted odds ratio 2.19, p 5 0.03).
Other clinical events occurring over four subsequent years
of follow-up analyzed for the three subgroups of patients
with specified degrees of one-year MJI are delineated in
Table 4. Cardiac death was infrequent but did increase with
each increment of myocardial jeopardy. Increasing MJI was
highly significantly associated with the need for subsequent
bypass surgery (p 5 0.008). There was a nonsignificant
trend suggesting higher risk of a major cardiac event in
follow-up with increasing degrees of MJI at one year (p 5
0.12).
DISCUSSION
The one-year angiographic substudy of BARI was under-
taken to determine the relative degrees of revascularization
provided by an initial strategy of angioplasty versus an initial
strategy of bypass surgery in selected patients with multives-
sel disease. A second objective was to determine the rela-
tionship of extent of revascularization to clinical status.
Extent of revascularization as assessed by the calculated MJI
was significantly improved at one-year follow-up with both
bypass surgery and angioplasty, but improvement was
greater with surgery than PTCA. The study confirms more
complete revascularization with bypass surgery than with
angioplasty at one year, despite more frequent repeat revas-
cularization procedures in angioplasty patients. Angina
status was concomitantly better with bypass surgery than
angioplasty, and the degree of improvement in angina
outweighed the degree of improvement in MJI, suggesting
that there are factors beyond the angiographically estimated
extent of revascularization involved in the perception of
angina. Increasing levels of one-year MJI were associated
with increasing requirement for subsequent bypass surgery
in follow-up. One-year wall motion and ejection fraction, as
well as change from baseline in these parameters, were not
different between the CABG and PTCA groups.
Completeness of revascularization. Completeness of re-
vascularization has long been argued to be predictive of
follow-up events in bypass surgery patients (30–33). How-
ever, the extent of revascularization has not been unequivo-
cably proven to be predictive of outcome in angioplasty
patients (34–43). Therefore, BARI was designed to treat
patients with multivessel disease and significant ischemia
without requiring that the proposed PTCA procedure(s)
provides revascularization anatomically equivalent to that
provided by surgery. Indeed, study results confirm that
surgery provided more complete revascularization than
PTCA by initial strategy and also at one year.
Completeness of revascularization at one year with
PTCA is affected by initial strategy of lesions attempted, by
success or failure of the PTCA, by restenosis of a subgroup
of initially successfully dilated lesions and by progression of
native coronary disease. Of the 60 angioplasties performed
following the initial revascularization procedure in patients
randomized to PTCA, 51 (85.0%) included an attempt of a
lesion previously dilated at the index procedure (restenosis),
24 (40.0%) included an attempt of a lesion not previously
dilated at the index procedure (new lesion) and 15 (25.0%)
included an attempt of both a restenotic lesion and a new
lesion. Target vessel repeat revascularization was performed
in 40.0% of 50 PTCA patients with initially complete
revascularization versus 45.9% of 74 patients with initially
incomplete revascularization (p 5 0.58). Thus, intent of the
angioplasty operator to provide complete versus incomplete
revascularization did not appear to influence the high
incidence of subsequent repeat revascularization procedures
in this angiographic substudy.
Less complete revascularization with PTCA was not
associated with worsened ejection fraction or LV wall
motion at one-year follow-up compared with surgery. With
both treatments, patients had equal wall motion score and
ejection fraction at one year. However, higher degrees of
myocardial jeopardy at one year were associated with an
increased frequency of subsequent bypass surgery.
Table 4. Long-Term (Four Year) Clinical Events After One-Year Angiography
Event
One Yr MJI
<10% (N 5 100)
One Yr MJI 10–33%
(N 5 106)
One Yr MJI
>33% (N 5 64) p
Cardiac death 1.0% 1.9% 3.1% 0.62
QMI 4.0% 2.8% 4.7% 0.81
CABG 2.0% 5.7% 14.1% 0.008
PTCA 10.0% 11.3% 15.6% 0.54
CABG or PTCA 11.0% 16.0% 25.0% 0.06
MACE 15.0% 18.9% 28.1% 0.12
CABG 5 coronary artery bypass grafting; MACE 5 major adverse cardiac event (cardiac death, QMI, CABG or PTCA);
MJI 5 myocardial jeopardy index; PTCA 5 percutaneous transluminal coronary angioplasty; QMI 5 Q-wave myocardial
infarction.
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Angina status. The previously reported improved angina
status of bypass surgery patients over PTCA randomized
patients at one year (20,21) was confirmed in this angio-
graphic substudy. Myocardial jeopardy index was more
predictive of angina in PTCA patients than in CABG
patients. The degree of anatomical revascularization and
resultant MJI differences between the two treatment options
is certainly part of the explanation for the greater relief of
angina with surgery. However, these data suggest that there
are additional factors involved in angina beyond the ana-
tomical degree of revascularization, as surgery provided
greater relief of angina than PTCA even with a similar
degree of myocardial jeopardy. The reason for this finding is
likely multifactorial, including both psychological factors
such as the relief of cognitive dissonance and physiologic
factors such as change of pain perception associated with an
operative procedure or a perioperative MI. In addition,
angiography is not a perfect method of assessing the
angina-provoking potential of coronary disease. No attempt
was made in this analysis to account for stenoses .50%
subserving “infarcted myocardium” because of the inade-
quacy of angiography in classifying myocardial viability.
This limitation and the small sample size analyzed may have
affected the low incidence of angina found in bypass surgery
patients with .33% MJI, who had 10.5% Q-wave MI
incidence by one year compared with 0 for PTCA patients
in the same jeopardy category, p 5 0.03. This study was not
designed to determine the mechanisms involved in angina
perception, and, therefore, we can only speculate about and
document this interesting phenomenon.
This angiographic substudy reports patient status at one
particular time point, and most patients with severe angina
at one-year angiography were treated with further revascu-
larization. In the complete BARI cohort, angina status
differences between PTCA and surgical patients were at-
tenuated by three years with both groups experiencing
similar angina relief at five years (20,21). It is therefore
reasonable to expect that this will be the case for the BARI
subgroup that was angiographically studied with the angio-
plasty patients requiring a greater number of revasculariza-
tion procedures.
Internal mammary artery versus saphenous vein bypass
graft patency. The one-year patency of 98% for internal
mammary artery grafts in this study of 135 consecutive
patients establishes a benchmark for current bypass surgery.
The one-year patency of saphenous vein grafts performed by
the same group of surgeons was 87%, similar to previous
data reported in the early and mid 1980s (44,45). These data
are consistent with the current trend in clinical care to
utilize mammary artery grafts in virtually all patients under-
going elective bypass surgery.
Study limitations. The angiographic substudy included
only 15% of the BARI randomized cohort, and therefore
extrapolating conclusions based on this subgroup to the
entire group is based on the relative similarity of baseline
characteristics and five-year clinical course between the
angiographically restudied subgroup and the other random-
ized BARI patients. The finding of more angina at one year
with PTCA in the angiography cohort was also similar to
that reported in the main BARI trial (20). Similar concur-
rence was observed in the subgroup analysis of economics
and quality of life (21). While it would have been desirable
to have a larger substudy, the authors feel that the results of
this study of consecutive patients are both interesting and
representative.
Angiography clearly has limitations in the assessment of
the severity of coronary disease, and alternative methods
(intravascular ultrasound, flow reserve, or fractional flow
reserve measurement or even routine stress testing) would
have been helpful to compare to these angiographic analy-
ses. However, these data were not collected in BARI, and
therefore are not available for comparison.
Conclusions. In this cohort of protocol-driven angio-
graphically restudied patients in the BARI trial at one year,
those having initial PTCA were more likely to report angina
than those having CABG. Reduction in myocardial jeop-
ardy for PTCA patients was also less than for CABG
patients despite more repeat revascularization procedures in
the angioplasty group. Increased MJI was related to in-
creased frequency of angina at one year, and to an increased
need for CABG in the four subsequent years of follow-up.
At one year after revascularization, every increase of 10
percentage units in myocardial jeopardy increased the prob-
ability of angina by 28%.
Reprint requests and correspondence: Patrick L. Whitlow, De-
partment of Cardiology, F25, The Cleveland Clinic Foundation,
9500 Euclid Avenue, Cleveland, Ohio 44195. E-mail:
whitlop@ccf.org.
APPENDIX
Myocardial jeopardy was calculated from an anatomic rep-
resentation of the size and distribution of coronary arteries
and their major branches, with the percentage of estimated
myocardium distal to $50% stenoses considered “jeopar-
dized.” Each major branch vessel (diagonals, circumflex
marginals, ramus, posterior descending and posterolateral
arteries) was assigned a territory unit of 1 (small), 2
(medium) or 3 (large), based on the vessel’s size and length.
The distal terminating portions of the left anterior descend-
ing, right coronary artery and circumflex vessels were sim-
ilarly sized. Three units of territory were assigned to the
septal vessels. By using a graphic database, each patient’s
coronary distribution to LV myocardium was characterized
and total LV units computed. Coronary lesions were posi-
tioned appropriately in relation to vessel branches and
bifurcations in each patient. The total LV myocardial units
jeopardized by lesions $50% were summed. The ratio of the
number of units of LV myocardium jeopardized by $50%
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lesions divided by the total LV territory units, expressed as
a percentage, defined the extent of myocardial jeopardy.
Coronary angioplasty mitigated all of the jeopardy distal
to lesions that were successfully dilated to a stenosis below
50%. Similarly, bypass grafts mitigated all jeopardy distal to
the insertion site of the graft and retrograde, including
branches, up to the point of a more proximal lesion that is
$50% severity. Myocardial jeopardy expressed as a percent
provides a semiquantitative, continuous variable measure-
ment of the amount of LV myocardium that is subject to
ischemia by $50% stenoses. The reproducibility of this
measurement has been assessed in blinded recycling of 70
angiograms. The mean difference between readings was 3.2
units with a standard deviation of 11.8 jeopardy units. The
intraclass correlation of readings was 0.77.
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